| 000 | 01678 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515054310.0 | ||
| 264 | 0 | _c20070607 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1059-1311 | ||
| 024 | 7 |
_a10.1016/j.seizure.2006.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeake, D | |
| 245 | 0 | 0 |
_aRetention rate of levetiracetam in children with intractable epilepsy at 1 year. _h[electronic resource] |
| 260 |
_bSeizure _cMar 2007 |
||
| 300 |
_a185-9 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdolescent Behavior _xdrug effects |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChild Behavior _xdrug effects |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPatient Dropouts _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPiracetam _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aMordekar, S | |
| 700 | 1 | _aGosalakkal, J | |
| 700 | 1 | _aMukhtyar, B | |
| 700 | 1 | _aBuch, S | |
| 700 | 1 | _aCrane, J | |
| 700 | 1 | _aWheway, R | |
| 700 | 1 | _aRittey, C | |
| 700 | 1 | _aDonnelly, J | |
| 700 | 1 | _aWhitehouse, W P | |
| 700 | 1 | _aPhilip, S | |
| 773 | 0 |
_tSeizure _gvol. 16 _gno. 2 _gp. 185-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.seizure.2006.12.001 _zAvailable from publisher's website |
| 999 |
_c16820334 _d16820334 |
||